Strategic partnership Avadyne Health joined Meduit in 2021, forming one of the nation’s larger RCM groups. This suggests cross-sell opportunities across a broader healthcare revenue cycle management suite and potential collaboration on end-to-end financial clearance and patient responsibility solutions.

AI driven gains MeduitAI and a full suite of RCM services indicate a strong emphasis on leveraging artificial intelligence to improve recoveries and reduce costs. Opportunities exist to upsell advanced AI-enabled patient financial engagement, denial management, and predictive financial clearance tools.

Patient financial focus Awards and recognition for patient financial communication and a specialty in patient liability resolution highlight a proven capability in improving patient experience and payment outcomes, making Avadyne a prime target for expanding patient-facing financing programs and clarity initiatives.

Mid-market potential With 51-200 employees and revenue in the mid tens of millions, Avadyne Health sits in the mid-market segment that can benefit from scalable outsourcing of RCM functions, including self-pay, Medicaid eligibility, bad debt, and legacy work, enabling growth for both parties.

Tech stack readiness Existing tech footprint including AWS, HubSpot, Sage, and Office 365 points to readiness for integration with modern revenue cycle platforms and marketing automation. There are opportunities to propose integrated solutions and joint go-to-market approaches leveraging current infrastructure.